Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 1, 2015, Pages 54-59

  Torok, Jordan A ^a   Wu, Yuan ^b   Prosnitz, Leonard R ^a   Kim, Grace J ^a   Beaven, Anne W ^a   Diehl, Louis F ^a   Kelsey, Chris R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

ADDITIONAL CYCLES; CARDIAC COMPLICATIONS; COMBINED MODALITY THERAPY; CONFIDENCE INTERVAL; FUNCTIONAL IMAGING; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; PROGRESSION FREE SURVIVAL;

POSITRON EMISSION TOMOGRAPHY;

BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; DYSPNEA; EARLY CANCER; ESOPHAGITIS; ESOPHAGUS STENOSIS; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LARGE CELL LYMPHOMA; LOW ENERGY RADIATION; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MUSCLE ATROPHY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION FIELD; RADIATION INDUCED NEOPLASM; SECOND CANCER; SMALL CELL LUNG CANCER; SURVIVAL TIME; VOCAL CORD PARALYSIS; YOUNG ADULT; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; PROCEDURES; RADIATION DOSE; RETROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; VINBLASTINE; YOUNG ADULT;

EID: 84927546624     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.02.003     Document Type: Article

References (30)

1. A.E. Hay, B. Klimm, and B.E. Chen An individual patient-data comparison of combined modality therapy and abvd alone for patients with limited-stage hodgkin lymphoma Ann Oncol 24 2013 3065 3069
2. C. Herbst, F.A. Rehan, and C. Brillant Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: A systematic review Haematologica 95 2010 494 500
3. B. Klimm, H. Goergen, and M. Fuchs Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: An analysis of international staging definitions Ann Oncol 24 2013 3070 3076
4. A. Engert, A. Plutschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
5. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable hodgkin's lymphoma: Final analysis of the German Hodgkin study group hd11 trial J Clin Oncol 28 2010 4199 4206
6. B. von Tresckow, A. Plutschow, and M. Fuchs Dose-intensification in early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin study group hd14 trial J Clin Oncol 30 2012 907 913
7. A. Engert, V. Diehl, and J. Franklin Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study J Clin Oncol 27 2009 4548 4554
8. K. Bauer, N. Skoetz, and I. Monsef Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage hodgkin lymphoma Cochrane Database Syst Rev 2011 CD007941
9. S.H. Swerdlow, E. Campo, and N.L. Harris WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Press Lyon, France
10. P.P. Carbone, H.S. Kaplan, and K. Musshoff Report of the committee on Hodgkin's disease staging classification Cancer Res 31 1971 1860 1861
11. M.E. Juweid, S. Stroobants, and O.S. Hoekstra Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of international harmonization project in lymphoma J Clin Oncol 25 2007 571 578
12. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 suppl 1 2002 79 83
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. M. Loeffler, V. Diehl, and M. Pfreundschuh Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease J Clin Oncol 15 1997 2275 2287
15. J.H. Elconin, K.B. Roberts, and D.A. Rizzieri Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy Int J Radiat Oncol Biol Phys 48 2000 1097 1105
16. G.A. Viani, M.S. Castilho, and P.E. Novaes Chemotherapy followed by low dose radiotherapy in childhood Hodgkin's disease: Retrospective analysis of results and prognostic factors Radiat Oncol 1 2006 38
17. J.A. Barnes, A.S. LaCasce, and K. Zukotynski End-of-treatment but not interim pet scan predicts outcome in nonbulky limited-stage hodgkin's lymphoma Ann Oncol 22 2011 910 915
18. R. Advani, L. Maeda, and P. Lavori Impact of positive positron emission tomography on prediction of freedom from progression after Stanford v chemotherapy in Hodgkin's disease J Clin Oncol 25 2007 3902 3907
19. D.J. Sher, P.M. Mauch, and A. Van Den Abbeele Prognostic significance of mid- and post-abvd pet imaging in Hodgkin's lymphoma: The importance of involved-field radiotherapy Ann Oncol 20 2009 1848 1853
20. J.M. Raemaekers, M.P. Andre, and M. Federico Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial J Clin Oncol 32 2014 1188 1194
21. M. Picardi, A. De Renzo, and F. Pane Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans Leuk Lymphoma 48 2007 1721 1727
22. D.L. Friedman, L. Chen, and S. Wolden Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from the children's oncology group study AHOD0031 J Clin Oncol 32 2014 3651 3658
23. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108
24. L.B. Travis, M. Gospodarowicz, and R.E. Curtis Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192
25. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
26. M.C. Hull, C.G. Morris, and C.J. Pepine Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy JAMA 290 2003 2831 2837
27. G. Schellong, M. Riepenhausen, and C. Bruch Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies Pediatr Blood Cancer 55 2010 1145 1152
28. B.F. Koontz, J.P. Kirkpatrick, and R.W. Clough Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications J Clin Oncol 24 2006 605 611
29. B. Omer, N.S. Kadan-Lottick, and K.B. Roberts Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults Br J Haematol 158 2012 615 625
30. S. Laskar, D.P. Kumar, and N. Khanna Radiation therapy for early stage unfavorable Hodgkin lymphoma: Is dose reduction feasible? Leuk Lymphoma 55 2014 2356 2361